Presentation of colonic carcinoma via genetic testing in the offspring
Familial adenomatous polyposis is an autosomal dominant condition with more than 90% penetrance, and the genetic mutation has been located to the short arm of chromosome five1. Gardner's syndrome is a disease variant, exhibiting extracolonic lesions including multiple epithelial cysts, desmoid tumours and osteomas in addition to multiple colonic polyps. Genetic tests will allow presymptomatic diagnosis of familial adenomatous polyposis in the relatives of those with the genetic mutation2. We describe a patient in whom Gardner's syndrome was diagnosed only when her child underwent chromosomal analysis because of minor facial dysmorphic features.
CASE HISTORY
A 34-year-old primigravida gave birth to a son who showed mild dysmorphic features (brachycephaly, epicanthic folds and bilateral simian creases). On chromosomal analysis the son and subsequently the mother were found to have identical pericentric inversion of chromosome five with break points at pl5.1 in the short arm and q22 in the long arm. There was no gain or loss of chromosomal material at the level of light microscopy.
It was only on direct questioning that the patient disclosed a one year history of rectal bleeding with passage of mucus. Stool frequency had also increased in the previous two months. Her appetite and weight were normal. Multiple lipomata and epithelial cysts had been excised from the forearms ten years previously and a bony tumour had been removed from the foot as a child. Her father had died aged 29 of colonic carcinoma with hepatic metastases and her only sister had been stillborn.
At colonoscopy multiple polyps were found throughout the colon with a malignant stricture in the sigmoid colon. She underwent a total colectomy and ileorectal anastomosis. The liver was normal by palpation. The resected colon contained two ulcerating tumours, one in the caecum and the other in the sigmoid colon. In addition there were multiple pedunculated polyps, concentrated especially in the distal sigmoid; sessile polyps were also scattered throughout the colon. Microscopy revealed a moderately differentiated invasive adenocarcinoma in the sigmoid colon with full-thickness bowel wall invasion and pericolic fat infiltration. The resection margins were clear of tumour and three out of five lymph nodes related to this tumour showed metastatic carcinoma; the highest lymph node was clear of tumour. Two of the distal polyps (tubulovillous adenomata) also showed early invasion of the stalks. The ulcerated caecal tumour and four other polyps were tubulovillous adenomata without evidence of invasion. She underwent adjuvant chemotherapy (5-fluorouracil and folinic acid) but did not complete the twelve-month course because of central line sepsis and pulmonary emboli.
One year later she returned with a right hypochondrial mass and at re-laparotomy an 8 cm retroperitoneal mass was found involving the origin of the superior mesenteric artery with small bowel adherent at the duodenojejunal flexure. This was judged to be non-resectable. There was a similar 3 cm mass in the left anterior abdominal wall. Biopsies of these lesions revealed desmoid tumours. ' Subsequent upper and lower gastrointestinal endoscopic surveillance has shown recurrent benign fundic and rectal polyps which were amenable to local resections. Three years after the original laparotomy she remains well with no evidence of carcinoma recurrence and the desmoid tumours remain fairly constant in size. Since there is a high risk of further polyps and cancers growing in the rectal stump, she has been advised to undergo lifelong endoscopic surveillance. COMMENT Familial adenomatous polyposis is characterized by the presence of hundreds to thousands of adenomatous polyps throughout the colon and rectum. Some of the tumours will undergo malignant transformation if left and the only effective treatment is prophylactic colectomy. The offspring of a patient with familial adenomatous polyposis has a 50% chance of inheriting the gene defect and, until recently, screening for symptom-free individuals has consisted of regular colonic examinations3. This would typically begin around puberty and continue for about 20 years.
With the localization of the adenomatous polyposis coli (APC) gene to chromosome 5q2 I and its subsequent characterization, it has become feasible to screen at-risk individuals with a one-off genetic test instead of repeated colonic examinations. Many different mutations have been identified by molecular analysis of the APC gene but each mutation seems to be unique to that family.
The family screening process is typically initiated when a patient is diagnosed with polyposis. All first-degree relatives would be traced and screened, and, if found positive, their offspring would also be investigated. With the use of a regional polyposis register, both the age at diagnosis of familial adenomatous polyposis and the incidence of cancer are reduced4.
In this unusual case it was the offspring who was found incidentally to have a disruption of chromosome five around the site of the APC gene; and the death of the patient's father from colonic carcinoma at the unusually early age of 29 years was another pointer to the possibility of an underlying genetic cancer syndrome. With the family history, the previous history of multiple cysts and an osteoma, the diagnosis of Gardner's syndrome was suspected and later confirmed in the patient. The child himself will be at risk of polyposis in later life and requires long-term follow-up. For a neuroendocrine tumour to secrete multiple peptides is not unusual. For more than one of these peptides to be functional is uncommon. We report such a case.
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CASE HISTORY
A 71-year-old woman was brought to casualty after an episode of syncope. She had been fasting in preparation for a barium enema, which had been arranged because of a sixweek history of profuse diarrhoea and associated weight loss of about 5 kg in three months. The patient also complained of episodes of epigastric discomfort. The only relevant medical history was the recent diagnosis of hypothyroidism, based on a plasma thyroxine of 39 nmol/L (normal 50-1 50) and thyroid stimulating hormone of 90mU/L (0.5-5.0). The only medication on admission was eltroxin; in particular, she was not taking a non-steroidal antiinflammatory drug.
On initial examination she was thin, pale and clammy with a sinus tachycardia of 120 beats per minute. A fourfinger non-tender hepatomegaly was palpable and she was faecal occult blood positive.
Glucose was 1.1 mmol/L (normal 0.8-8.3), erythrocyte sedimentation rate 60 mm/h, lactate dehydrogenase 890 IU/L (240-450), aspartate aminotransferase 57 IU/L (7-40), albumin 30 g/L (35-50). Abdominal ultrasound showed multiple echogenic lesions scattered throughout the liver. A computerized tomographic scan confirmed the presence of these lesions, which were consistent with liver metastases. Gastroscopy revealed grade three oesophagitis,
